OXFORD ASSET MANAGEMENT LLP - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 46 filers reported holding PROQR THRAPEUTICS N V in Q1 2020. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
OXFORD ASSET MANAGEMENT LLP ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q4 2019$786,000
+113.0%
79,336
+23.8%
0.02%
+144.4%
Q3 2019$369,000
-48.0%
64,083
+42.4%
0.01%
-50.0%
Q4 2018$710,000
-65.8%
45,014
-57.9%
0.02%
-58.1%
Q3 2018$2,077,000
+3250.0%
106,959
+429.5%
0.04%
+4200.0%
Q1 2018$62,000
-27.9%
20,199
-25.7%
0.00%
-50.0%
Q4 2017$86,00027,1690.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q1 2020
NameSharesValueWeighting ↓
M28 Capital Management LP 1,910,600$2,483,7802.85%
Privium Fund Management B.V. 5,344,446$6,947,7802.07%
DAFNA Capital Management LLC 940,582$1,222,7570.38%
Monaco Asset Management SAM 377,517$490,7720.15%
EcoR1 Capital, LLC 2,980,016$3,874,0210.13%
Ikarian Capital, LLC 472,625$614,4120.07%
FRANKLIN STREET ADVISORS INC /NC 150,000$1950.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$4,713,1070.01%
GSA CAPITAL PARTNERS LLP 74,084$960.01%
UBS OCONNOR LLC 189,328$246,1260.01%
View complete list of PROQR THRAPEUTICS N V shareholders